
We're looking for a Senior Specialist External Quality to join our team and play a critical role in supporting the transfer and manufacture of innovative medicines through our global network of Contract Manufacturing Organisations (CMOs).
In this highly visible role, you'll partner with Product Development, Clinical Supply, Manufacturing, and External Supply teams to ensure quality is embedded throughout the technical transfer process for both clinical and commercial products. You'll provide quality leadership, help drive compliance and continuous improvement, and work collaboratively with internal and external stakeholders to ensure successful delivery of key milestones.
This is an excellent opportunity for a quality professional who enjoys working across complex projects, influencing stakeholders, and making a real impact on patient supply.
Why join us?
You'll be joining a collaborative and innovative environment where quality is at the heart of everything we do. This role offers the opportunity to work on complex global projects, build strong partnerships across a diverse stakeholder group, and help ensure that life-changing medicines reach patients around the world.
If you're passionate about quality, continuous improvement and delivering excellence in pharmaceutical manufacturing, we'd love to hear from you.
16-Sept-2026
30-Sept-2026
Our mission is to build an inclusive and equitable environment. We want people to feel they belong at AstraZeneca and Alexion, starting with our recruitment process. We welcome and consider applications from all qualified candidates, regardless of characteristics. We offer reasonable adjustments/accommodations to help all candidates to perform at their best. If you have a need for any adjustments/accommodations, please complete the section in the application form.

Alexion, AstraZeneca Rare Disease is focused on pioneering new possibilities for the rare disease community. We are driven by a mission to change what it means to live with a rare disease.
A leader in rare disease for more than three decades and today continues to build a diversified pipeline across disease areas with significant unmet need, using an array of innovative modalities.
As part of AstraZeneca, Alexion is continually expanding its global geographic footprint to serve more rare disease patients around the world. It is headquartered in Boston, US.
Alexion’s pioneering legacy in rare disease is rooted in being the first to translate the complex biology of the complement system into novel medicines. Alexion pushes boundaries to accelerate discovery of life-changing medicines. Headquartered in Boston, Massachusetts, Alexion has offices around the world and continues to expand its reach to benefit more people globally.
GL/NP/0116
GL/NP/0095
Community Guidelines: https://bit.ly/39x9gqy